Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10956)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 8, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gomaa AI, Waked I. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol 2015; 7(4): 673-687 [PMID: 25866604 DOI: 10.4254/wjh.v7.i4.673] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i4/673.htm |
| Number | Citing Articles |
| 1 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
|
| 2 |
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Clara Romanholi Passos, Camila Sanches Manca, Isabela Laurencio Schiavoni, Andreza Correa Teixeira, Ana de Lourdes Candolo Martinelli, Paula Garcia Chiarello. Hand grip strength and adductor pollicis muscle thickness in patients on palliative care for hepatocellular carcinoma. Clinical Nutrition Experimental 2018; 22: 30 doi: 10.1016/j.yclnex.2018.06.003
|
| 3 |
Khaled Farid, Hatem Elalfy, Salwa M. Abo El-khair, Hoda Elgamal, Tarek Besheer, Ali Elmokadem, Walaa Shabana, Sally Abed, Mohamed Elegezy, Ahmed Abd El-khalek, Ahmed El-Morsy, Amr Negm, Ayman Z. Elsamanoudy, Basem El deek, Talal Amer, Mahmoud El-Bendary. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients. Expert Review of Gastroenterology & Hepatology 2020; 14(12): 1203 doi: 10.1080/17474124.2020.1823215
|
| 4 |
Ruiqi Liu, Hong Li, Yihua Qiu, Hongguang Liu, Zhen Cheng. Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides. Pharmaceuticals 2022; 15(11): 1339 doi: 10.3390/ph15111339
|
| 5 |
Xinmin Guo, Shunhua Guo, Liwen Pan, Li Ruan, Yingshi Gu, Jichuang Lai. Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells. Oncology Letters 2017; 13(5): 3669 doi: 10.3892/ol.2017.5910
|
| 6 |
Hojung Jung, Byung Ik Kim, Yong Kyun Cho, Woo Kyu Jeon, Hong Joo Kim, Hyun Pyo Hong. Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: case report with 8-year follow up. Clinical and Molecular Hepatology 2018; 24(4): 424 doi: 10.3350/cmh.2017.0032
|
| 7 |
Zeng Wang-Yuan, Zeng Jiang-Zheng, Yan-Da Lu, Xin-Bao Hao, Tao Hong, Fen Huang, Jun-Hua Lei, Zhi-Hui He, Mei-zhu Huang. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. International Journal of Hyperthermia 2016; 32(2): 193 doi: 10.3109/02656736.2015.1099168
|
| 8 |
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesis. Biomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
|
| 9 |
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera. Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepatic Oncology 2018; 5(2): HEP08 doi: 10.2217/hep-2018-0002
|
| 10 |
Begum Dariya, Sujatha Peela, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 1 doi: 10.1016/B978-0-323-98806-3.00001-5
|
| 11 |
Olivier Sutter, Joyce Calvo, Gisèle N’Kontchou, Jean-Charles Nault, Raffik Ourabia, Pierre Nahon, Nathalie Ganne-Carrié, Valérie Bourcier, Nora Zentar, Fatna Bouhafs, Nicolas Sellier, Abou Diallo, Olivier Seror. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series. Radiology 2017; 284(3): 877 doi: 10.1148/radiol.2017161413
|
| 12 |
Ming Jia, Yulin Xiong, Maoshi Li, Qing Mao. Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2020; 28(4): 371 doi: 10.3727/096504020X15853075736554
|
| 13 |
Xue-Fen Lei, Yang Ke, Tian-Hao Bao, Hao-Ran Tang, Xue-Song Wu, Zhi-Tian Shi, Jie Lin, Zhi-Xian Zhang, Hou Gu, Lin Wang. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74
|
| 14 |
Maria Pipa-Muñiz, Lluis Castells, Sonia Pascual, Javier Fernández-Castroagudín, Iratxe Díez-Miranda, Javier Irurzun, Roberto Díaz-Beveridge, María Senosiaín, Juan Arenas, Manuel de la Mata, Juan Turnes, María Isabel Monge-Romero, Daniel Pérez-Enguix, Javier Bustamante-Schneider, Nora Otegui, Esther Molina-Pérez, José Eduardo Rodríguez-Menéndez, Maria Varela. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study. Gastroenterología y Hepatología (English Edition) 2017; 40(8): 515 doi: 10.1016/j.gastre.2017.05.007
|
| 15 |
Chengxu Ruan, Lijuan You, Yingdong Qiu, Xiao Cui, Defeng Wu. Tubeimoside I induces autophagy in HepG2 cells by activating the AMP‑activated protein kinase signaling pathway. Oncology Letters 2020; 20(1): 623 doi: 10.3892/ol.2020.11604
|
| 16 |
Qing-Liang Wang, Xiao-Jie Li, Zhi-Cheng Yao, Peng Zhang, Shi-Lei Xu, He Huang, Kun-Peng Hu. Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case report. Molecular and Clinical Oncology 2017; 7(4): 693 doi: 10.3892/mco.2017.1363
|
| 17 |
Li‐Hua Luo, Min Jin, Lan‐Qing Wang, Guo‐Jie Xu, Zhen‐Yu Lin, Dan‐Dan Yu, Sheng‐Li Yang, Rui‐Zhi Ran, Gang Wu, Tao Zhang. Long noncoding RNA TCL6 binds to miR‐106a‐5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. Journal of Cellular Physiology 2020; 235(9): 6154 doi: 10.1002/jcp.29544
|
| 18 |
Yanfeng Shen, Feng Xi, Haibin Li, Yin Luo, Cheng Chen, Lei Wang. Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer. IUBMB Life 2018; 70(7): 642 doi: 10.1002/iub.1758
|
| 19 |
Wancai Zheng, Yujing Feng, Yujia Bai, Zuoshan Feng, Xijuan Yang, Bin Dang, Ming Xiao, Jianmei Zhang, Sheng-Qiang Han. Proanthocyanidins extracted from grape seeds inhibit the growth of hepatocellular carcinoma cells and induce apoptosis through the MAPK/AKT pathway. Food Bioscience 2022; 45: 101337 doi: 10.1016/j.fbio.2021.101337
|
| 20 |
Qing Lei, Xin Yan, Huimin Zou, Yixuan Jiang, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis. Discover Oncology 2022; 13(1) doi: 10.1007/s12672-022-00559-1
|
| 21 |
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma. Journal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
|
| 22 |
Yuxin Liang, Zirui Wang, Yujiao Peng, Zonglin Dai, Chunyou Lai, Yuqin Qiu, Yutong Yao, Ying Shi, Jin Shang, Xiaolun Huang. Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1169102
|
| 23 |
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
|
| 24 |
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectives. Expert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
|
| 25 |
P. Venkat, S.E. Hoffe, J.M. Frakes. Handbook of Supportive and Palliative Radiation Oncology. 2017; : 231 doi: 10.1016/B978-0-12-803523-8.00015-0
|
| 26 |
Brian I. Carr, Srikanth Nagalla, Ravit Geva. Hepatocellular Carcinoma. 2016; : 489 doi: 10.1007/978-3-319-34214-6_33
|
| 27 |
Christina A. Arnold, Maryam K. Pezhouh, Dora Lam-Himlin, Meredith E. Pittman, Christopher VandenBussche, Lysandra Voltaggio. 90Y-TheraSpheres. American Journal of Surgical Pathology 2019; 43(5): 688 doi: 10.1097/PAS.0000000000001223
|
| 28 |
Xinhua Chen, Zhigang Ren, Shengyong Yin, Yuning Xu, Danjing Guo, Haiyang Xie, Lin Zhou, Liming Wu, Jianwen Jiang, Hongchun Li, Junhui Sun, Shusen Zheng. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profile. Cytokine 2017; 93: 44 doi: 10.1016/j.cyto.2017.05.003
|
| 29 |
Maria Pipa-Muñiz, Lluis Castells, Sonia Pascual, Javier Fernández-Castroagudín, Iratxe Díez-Miranda, Javier Irurzun, Roberto Díaz-Beveridge, María Senosiaín, Juan Arenas, Manuel de la Mata, Juan Turnes, María Isabel Monge-Romero, Daniel Pérez-Enguix, Javier Bustamante-Schneider, Nora Otegui, Esther Molina-Pérez, José Eduardo Rodríguez-Menéndez, Maria Varela. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study. Gastroenterología y Hepatología 2017; 40(8): 515 doi: 10.1016/j.gastrohep.2017.05.009
|
| 30 |
Julian Biau, Flavien Devun, Pierre Verrelle, Marie Dutreix. Dbait : un concept innovant pour inhiber la réparation de l’ADN et contribuer aux traitements des cancers. Bulletin du Cancer 2016; 103(3): 227 doi: 10.1016/j.bulcan.2016.01.007
|
| 31 |
Rania E. Mohamed, Mohamed A. Amin, Hazem M. Omar. Apparent diffusion coefficient and dynamic contrast-enhanced MRI as reliable biomarkers for evaluating response to locoregional therapy in hepatocellular carcinoma patients. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4): 914 doi: 10.1016/j.ejrnm.2018.07.012
|
| 32 |
Hamed Hemati, Jagdeep Kaur, R.C. Sobti, Nirupma Trehanpati. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3. Biochemical and Biophysical Research Communications 2020; 525(4): 941 doi: 10.1016/j.bbrc.2020.03.009
|
| 33 |
Huimin Zou, Qing Lei, Xin Yan, Yunfeng Lai, Carolina Oi Lam Ung, Hao Hu. Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis. Cancers 2022; 15(1): 260 doi: 10.3390/cancers15010260
|
| 34 |
Lu Fan, Huayun Zhu, Weiwei Tao, Li Liu, Xin Shan, Ming Zhao, Dongdong Sun. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3. Phytomedicine 2019; 62: 152931 doi: 10.1016/j.phymed.2019.152931
|
| 35 |
Yu Zeng, Qin Xu, Nan Xu. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway. Bioengineered 2021; 12(1): 7964 doi: 10.1080/21655979.2021.1984005
|
| 36 |
Quality of Life and Work Ability among Healthcare Personnel with Chronic Viral Hepatitis. Evaluation of the Inpatient Rehabilitation Program of the Wartenberg Clinic. International Journal of Environmental Research and Public Health 2019; 16(20): 3874 doi: 10.3390/ijerph16203874
|
| 37 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
|
| 38 |
Talia Baker, Parissa Tabrizian, Ivan Zendejas, Thomas Clark Gamblin, Marwan Kazimi, Karim Boudjema, David Geller, Riad Salem. Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. HPB 2022; 24(7): 1007 doi: 10.1016/j.hpb.2021.12.013
|
| 39 |
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
|
| 40 |
Charing Ching-Ning Chong, Grace Lai-Hung Wong. Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCC. AIMS Medical Science 2016; 3(1): 162 doi: 10.3934/medsci.2016.1.162
|
| 41 |
Weizhong Wu, Sanguang Liu, Yunfei Liang, Zegao Zhou, Xueqing Liu. MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarker. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0386-x
|
| 42 |
Xiaoran Zhang, Jinxiu Li, Meixing Yan. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin. Drug Development and Industrial Pharmacy 2016; 42(10): 1590 doi: 10.3109/03639045.2016.1160103
|
| 43 |
Doris Schneller, Peter Angel. Hepatocellular Carcinoma. 2019; : 1 doi: 10.15586/hepatocellularcarcinoma.2019.ch1
|
| 44 |
Eric A. Wang, Jeff P. Stein, Ross J. Bellavia, Scott R. Broadwell. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres. International Journal of Clinical Practice 2017; 71(11): e12972 doi: 10.1111/ijcp.12972
|
| 45 |
JING LI, OU LI, MUJIE KAN, MING ZHANG, DAN SHAO, YUE PAN, HUILIN ZHENG, XUEWEN ZHANG, LI CHEN, SONGYAN LIU. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Molecular Medicine Reports 2015; 12(3): 4572 doi: 10.3892/mmr.2015.3926
|
| 46 |
John Chun-Hao Chen, Hui-Yen Chuang, Fei-Ting Hsu, Yi-Chen Chen, Yi-Chun Chien, Jeng-Jong Hwang. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget 2016; 7(51): 85450 doi: 10.18632/oncotarget.13398
|
| 47 |
Yang Li, Dan-Yun Ruan, Chang-Chang Jia, Hui Zhao, Guo-Ying Wang, Yang Yang, Nan Jiang. Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treatment strategy. Hepatobiliary & Pancreatic Diseases International 2017; 16(5): 480 doi: 10.1016/S1499-3872(17)60052-3
|
| 48 |
A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC. Minimally Invasive Therapy & Allied Technologies 2021; 30(3): 163 doi: 10.1080/13645706.2019.1707689
|
| 49 |
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
|
| 50 |
Hla-Hla Thein, Yao Qiao, Ahmad Zaheen, Nathaniel Jembere, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle, Sheng-Nan Lu. Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting. PLOS ONE 2017; 12(10): e0185198 doi: 10.1371/journal.pone.0185198
|
| 51 |
Qiang Sun, Xiangda Zhang, Xueyi Gong, Zhipeng Hu, Qiao Zhang, Weiming He, Xiaojian Chang, Zemin Hu, Yajin Chen. Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data. Hepatology International 2021; 15(5): 1215 doi: 10.1007/s12072-021-10219-1
|
| 52 |
Christoph Eilenberger, Mario Rothbauer, Eva-Kathrin Ehmoser, Peter Ertl, Seta Küpcü. Effect of Spheroidal Age on Sorafenib Diffusivity and Toxicity in a 3D HepG2 Spheroid Model. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41273-3
|
| 53 |
Liping Qu, Huiqing Zhang, Yanlong Yang, Geliang Yang, Hailiang Xin, Changquan Ling. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathwayin vitro. Pharmaceutical Biology 2016; 54(8): 1445 doi: 10.3109/13880209.2015.1104699
|
| 54 |
Guanlin Zhou, Ying Li, Shicheng Li, Hongxia Liu, Fei Xu, Xiaohuan Lai, Qiong Zhang, Jingxiang Xu, Shaogui Wan. Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.719451
|
| 55 |
Nirmitha I. Herath, Flavien Devun, Aurélie Herbette, Marie-Christine Lienafa, Philippe Chouteau, Jian-Sheng Sun, Marie Dutreix, Alban Denys. Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models. European Radiology 2017; 27(10): 4435 doi: 10.1007/s00330-017-4792-1
|
| 56 |
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors. Medicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
|
| 57 |
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
|
| 58 |
J. Arend, K. Schütte, T. Däberitz, T. Bretschneider, F. Benedix, A. Udelnow, St. Wolff, C. J. Bruns. Lebertransplantation bei Malignomen und Vorläufererkrankungen. Der Onkologe 2016; 22(7): 451 doi: 10.1007/s00761-016-0052-2
|
| 59 |
Baxter Hepburn Kachingwe, Yow-Shieng Uang, Tsurng-Juhn Huang, Li-Hsuan Wang, Shwu-Jiuan Lin. Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies. Journal of Food and Drug Analysis 2018; 26(1): 401 doi: 10.1016/j.jfda.2017.09.003
|
| 60 |
Jichao Chen, Tianyu Wang, Shengtao Xu, Aijun Lin, Hequan Yao, Weijia Xie, Zheying Zhu, Jinyi Xu. Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents. European Journal of Medicinal Chemistry 2017; 132: 173 doi: 10.1016/j.ejmech.2017.03.027
|
| 61 |
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
|
| 62 |
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Therapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816287
|
| 63 |
Rixiong Wang, Nan Lin, Binbin Mao, Qing Wu. The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individuals. Journal of Cancer Research and Clinical Oncology 2022; 148(5): 1195 doi: 10.1007/s00432-021-03716-1
|
| 64 |
Claire Faltermeier, Ronald Busuttil, Ali Zarrinpar. A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases 2015; 3(4): 221 doi: 10.3390/diseases3040221
|
| 65 |
Mihaela Ignat, Cherif Youssef Akladios, Véronique Lindner, Konstantin Khetchoumian, Marius Teletin, Didier Muttter, Pierre Marc Aprahamian, Jacques Marescaux. Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0434-8
|
| 66 |
Shanshan Li, Yang Li, Hongjian Sun, Yang Jiang, Keming Pan, Yue Su, Nan Bu. Mulberry fruit polysaccharides alleviate diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis in vivo: the roles of cell apoptosis and inflammation. Bioengineered 2021; 12(2): 11599 doi: 10.1080/21655979.2021.1993716
|
| 67 |
Ines Barone, Cinzia Giordano, Daniela Bonofiglio, Sebastiano Andò, Stefania Catalano. Phosphodiesterase type 5 and cancers: progress and challenges. Oncotarget 2017; 8(58): 99179 doi: 10.18632/oncotarget.21837
|
| 68 |
Da-Wei Yeh, Xuyao Zhao, Hifzur R. Siddique, Mengmei Zheng, Hye Yeon Choi, Tatsuya Machida, Padmini Narayanan, Yi Kou, Vasu Punj, Stanley M. Tahara, Douglas E. Feldman, Lin Chen, Keigo Machida. MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01427-9
|